MELATONIN (doses of 10mg daily or less)

Clinical Indication

Sleep disorders children (see comments) continued in adults if proven efficacy in childhood

Comments

Yellow only applies to the products stated in the LMSG guidance. Other formulations are secondary care only.

 

Date of classification

May 2015

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.